Market Expansion Capitalize on Excelin Health’s national footprint of home health and hospice agencies to cross-sell advanced clinical programs such as LVAD patient management and post-acute care pathways to hospitals and health systems seeking integrated care transitions.

Tech Enablement Leverage their tech stack and digital patient engagement capabilities (Amplitude, iCIMS, CMS integrations) to offer value-added software solutions, data analytics, and API partnerships that streamline claims, patient outreach, and outcome tracking for payer and provider clients.

Clinical Programs Position high-acuity, condition-specific programs (CHF, COPD, diabetes, wounds, IV Infusion, LVAD coordination) as differentiators to health systems and payers seeking specialized home-based care to reduce readmissions and improve care transitions.

Growth Funding Target growth-stage health services investors and strategic buyers who previously invested in Excelin or similar home health operators, leveraging the company’s $10M-$25M revenue range and recent investment history to unlock potential partnerships, minority stakes, or acquisitions.

Operational Synergy Offer scalable operating solutions such as clinical program playbooks, staffing models, and telehealth-enabled nursing and therapy services to optimize efficiency across their 11-50 employees and multiple agencies, aligning with payer requirements and quality metrics.